The mitotic delay of two biochemically different G1 cell populations of cultured 48-hour stationary phase (S.P.) and synchronized pea root meristems was measured after exposure to 300 R of gamma rays. The indices of delay were the transition from G1 to S and the time required for the population to divide (G1 → S → G2 → M). The criteria for biochemical differences were the time required to enter the S period and the sensitivity of DNA synthesis initiation to actinomycin D, puromycin, and cycloheximide. The population of S.P. meristems was delayed in G1 for approximately 5 hours but subsequently traversed S and G2 at a control rate; puromycin treatment prevented all cells from advancing to S for at least 12 hours and none divided for 24 hours. Actinomycin D treatment failed to stop about 10% of the G1 cells from moving to S, and a few of these eventually divided. Synchronized cells at the G1/S boundary progressed to S unimpaired but were delayed somewhere in either S or G2 and they appeared in mitosis 6-7 hours later than the controls. When irradiated and treated with an inhibitor, these cells were not prevented from advancing to S. It was concluded that defective protein synthesis was the cause of delay in all irradiated G1 cells and that the time and cycle period where it occurred varied and was dependent on whether the requisite proteins for functional completion of a given period were already formed at the moment of exposure.
Skip Nav Destination
Research Article| December 01 1970
Mitotic Delay in Two Biochemically Different G1 Cell Populations in Cultured Roots of Pea (Pisum sativum)
Radiat Res (1970) 44 (3): 700–712.
- Views Icon Views
- Share Icon Share
- Search Site
Jack Van't Hof, C. J. Kovacs; Mitotic Delay in Two Biochemically Different G1 Cell Populations in Cultured Roots of Pea (Pisum sativum). Radiat Res 1 December 1970; 44 (3): 700–712. doi: https://doi.org/10.2307/3573150
Download citation file:
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Monte Carlo Simulation of SARS-CoV-2 Radiation-Induced Inactivation for Vaccine Development
Ziad Francis, Sebastien Incerti, Sara A. Zein, Nathanael Lampe, Carlos A. Guzman, Marco Durante
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Studies of the Mortality of Atomic Bomb Survivors, Report 14, 1950–2003: An Overview of Cancer and Noncancer Diseases
Kotaro Ozasa, Yukiko Shimizu, Akihiko Suyama, Fumiyoshi Kasagi, Midori Soda, Eric J. Grant, Ritsu Sakata, Hiromi Sugiyama, Kazunori Kodama
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner